BioCentury | Jan 30, 2021
Product Development

ALS looks up as clinical pipeline explodes

...and attention brought to the field by The ALS Association’s...
BioCentury | Oct 2, 2020
Product Development

With patient groups’ endorsement, Amylyx, FDA to discuss approval of ALS therapy

...trial that could give the venture-backed biotech a short path to a marketed drug.Two foundations, the ALS Association...
...Phase III trial, which would take three years and $100 million to get to market,” the ALS Association...
...drugs: provide approval and ask for a postmarket study.”Dave said this is the first time the ALS Association...
BioCentury | Sep 10, 2020
Product Development

Master protocols should not be a one-off phenomenon confined to COVID-19

...supported by several ALS patient organizations including The ALS Association. MGH...
BioCentury | Jul 2, 2020
Finance

Building on ALS results, Amylyx raises $30M ahead of Alzheimer’s readout

...subsisted on fairly little equity cash thus far, with ample support from philanthropic organizations including the ALS Association...
BioCentury | Jun 4, 2020
Politics, Policy & Law

Legislation creating provisional approval pathway introduced in U.S. Senate

...experimental. The Promising Pathway Act was endorsed by two patient groups, I AM ALS and The ALS Association...
BioCentury | Nov 7, 2019
Clinical News

ALS group launches trial of digital app to track progression

...totaling more than 80 different metrics. The work is funded by a $300,000 grant from the ALS Association...
BioCentury | Nov 3, 2017
Company News

Management tracks: Tissue Regenix, Therapix

...hired Stevan Gibson as president. He was chief mission strategy and public policy officer at The ALS Association...
BioCentury | Oct 24, 2017
Distillery Therapeutics

Neurology

INDICATION: Amyotrophic lateral sclerosis (ALS) Mouse and fruit fly studies suggest promoting HspA8 expression could help treat ALS. In muscle samples from mouse and Drosophila models of ALS overexpressing TDP-43 with the ALS-associated point mutations...
BioCentury | Sep 11, 2017
Politics & Policy

Drug development costs unsustainable, Gottlieb warns

...next year, including one for amyotrophic lateral sclerosis (ALS) that builds on work conducted by the ALS Association...
BioCentury | Mar 24, 2016
Translation in Brief

Biogen buddies up

...disease, an area in which it already has a preclinical partnership with Columbia University and The ALS Association...
Items per page:
1 - 10 of 27
BioCentury | Jan 30, 2021
Product Development

ALS looks up as clinical pipeline explodes

...and attention brought to the field by The ALS Association’s...
BioCentury | Oct 2, 2020
Product Development

With patient groups’ endorsement, Amylyx, FDA to discuss approval of ALS therapy

...trial that could give the venture-backed biotech a short path to a marketed drug.Two foundations, the ALS Association...
...Phase III trial, which would take three years and $100 million to get to market,” the ALS Association...
...drugs: provide approval and ask for a postmarket study.”Dave said this is the first time the ALS Association...
BioCentury | Sep 10, 2020
Product Development

Master protocols should not be a one-off phenomenon confined to COVID-19

...supported by several ALS patient organizations including The ALS Association. MGH...
BioCentury | Jul 2, 2020
Finance

Building on ALS results, Amylyx raises $30M ahead of Alzheimer’s readout

...subsisted on fairly little equity cash thus far, with ample support from philanthropic organizations including the ALS Association...
BioCentury | Jun 4, 2020
Politics, Policy & Law

Legislation creating provisional approval pathway introduced in U.S. Senate

...experimental. The Promising Pathway Act was endorsed by two patient groups, I AM ALS and The ALS Association...
BioCentury | Nov 7, 2019
Clinical News

ALS group launches trial of digital app to track progression

...totaling more than 80 different metrics. The work is funded by a $300,000 grant from the ALS Association...
BioCentury | Nov 3, 2017
Company News

Management tracks: Tissue Regenix, Therapix

...hired Stevan Gibson as president. He was chief mission strategy and public policy officer at The ALS Association...
BioCentury | Oct 24, 2017
Distillery Therapeutics

Neurology

INDICATION: Amyotrophic lateral sclerosis (ALS) Mouse and fruit fly studies suggest promoting HspA8 expression could help treat ALS. In muscle samples from mouse and Drosophila models of ALS overexpressing TDP-43 with the ALS-associated point mutations...
BioCentury | Sep 11, 2017
Politics & Policy

Drug development costs unsustainable, Gottlieb warns

...next year, including one for amyotrophic lateral sclerosis (ALS) that builds on work conducted by the ALS Association...
BioCentury | Mar 24, 2016
Translation in Brief

Biogen buddies up

...disease, an area in which it already has a preclinical partnership with Columbia University and The ALS Association...
Items per page:
1 - 10 of 27